.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent clinical evidence suggests a significant association between SGLT2 inhibitors stroke risk reduction in high-risk diabetic populations. Specifically, patients with type 2 diabetes (T2D) and diabetic retinopathy (DR) face a heightened threat of cerebrovascular events. This multicenter study explored whether sodium-glucose cotransporter-2 inhibitors (SGLT2i) could effectively mitigate these risks. Researchers compared SGLT2i users against those taking metformin or DPP-4 inhibitors using TriNetX data.
After meticulous matching, the results revealed substantial benefits for SGLT2i users. Notably, the risk of hemorrhagic stroke (HS) decreased by 24% within one year. This protective effect remained consistently lower throughout the five-year follow-up period. Furthermore, the risk of ischemic stroke (IS) showed a significant 8% reduction by the fifth year.
Subgroup analyses provided even more granular insights into patient outcomes. Patients with early-stage retinopathy and an HbA1c below 7% experienced the most pronounced benefits. Moreover, the study demonstrated consistent risk reductions in patients with neuropathy and chronic kidney disease. These findings highlight SGLT2 inhibitors as a versatile tool for managing macrovascular complications beyond glycemic control.
In conclusion, SGLT2 inhibitors offer significant cerebrovascular protection to patients with T2D and DR. While these retrospective findings are promising, clinicians should await prospective trials. Nevertheless, low numbers needed to treat suggest SGLT2i could be pivotal for diabetic care in India.
The study found that SGLT2 inhibitors provide a faster and more significant reduction in hemorrhagic stroke risk compared to ischemic stroke. While HS risk decreased within the first year, IS risk reduction became statistically significant at the five-year follow-up mark.
The research specifically focused on patients with diabetic retinopathy. However, sensitivity analyses confirmed that the protective benefits for hemorrhagic stroke remained consistent in patients with comorbid conditions like neuropathy, nephropathy, and chronic kidney disease.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Chen KE et al. Association of SGLT2 Inhibitor With Stroke in Type 2 Diabetes With Diabetic Retinopathy: A Multicenter Electronic Health Record Data Study. Diabetes Obes Metab. 2026 Apr 13. doi: 10.1111/dom.70744. PMID: 41969190.
Yen FS et al. SGLT2 Inhibitors and the Risk of Sight-Threatening Retinopathy in Patients With Type 2 Diabetes. JAMA Netw Open. 2023 Dec 20. doi: 10.1001/jamanetworkopen.2023.48440.
Wong KH et al. Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study. Stroke. 2020 Feb. doi: 10.1161/STROKEAHA.119.027961.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
SGLT2i therapy is associated with lower stroke risk, particularly hemorrhagic stroke, in T2D patients with diabetic retinopathy, according to a 5-year study...
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
